stockwatcher12
09-25-2009, 12:04 PM
Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) has notched 5.90% with an unusual huge volume of 4.41 million shares in the early morning trade and is trading at $2.89. Yesterday September 24, 2009 Chelsea Therapeutics International Ltd. announced top line results from Study 302, the first of two Phase III trials of Droxidopa for the treatment of symptomatic neurogenic orthostatic hypotension (NOH). While Study 302 demonstrated that Droxidopa showed a strong symptomatic benefit during the open-label dose titration and run-in phase of the trial………….
check out LiquidTycoon dot com bcuz they have a summary report on the company...cool site!
check out LiquidTycoon dot com bcuz they have a summary report on the company...cool site!